2014
Assessment concordance and predictive validity of self‐report and biological assay of cocaine use in treatment trials
Decker SE, Frankforter T, Babuscio T, Nich C, Ball SA, Carroll KM. Assessment concordance and predictive validity of self‐report and biological assay of cocaine use in treatment trials. American Journal On Addictions 2014, 23: 466-474. PMID: 24628970, PMCID: PMC4139466, DOI: 10.1111/j.1521-0391.2014.12132.x.Peer-Reviewed Original ResearchConceptsPredictive validityPsychosocial outcomesCocaine useSelf-report assessmentsSelf-report accuracyCocaine treatment trialSelf-reported dataPost-treatment pointSelf-reported cocaine useMethod variancePost-treatment outcomesTreatment trialsTreatment completionAssessment methodsUrinalysis resultsValidityRandomized clinical trials
1998
Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts
Petrakis I, Carroll K, Nich C, Gordon L, Kosten T, Rounsaville B. Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts. Drug And Alcohol Dependence 1998, 50: 221-226. PMID: 9649975, DOI: 10.1016/s0376-8716(98)00032-5.Peer-Reviewed Original ResearchConceptsCocaine useOpioid addictsMedication effectsDepressive symptomsSignificant decreaseEffectiveness of fluoxetineSelf-reported cocaine useDrug use outcomesSubsample of subjectsFluoxetine treatmentUrine toxicologySelf-reported useDepressive disorderSevere depressionHeroin useFluoxetineEffective agentUse outcomesDepressionPlaceboSignificant differencesTreatmentSymptomsAddictsMethadone